margarita25
Well-Known Member
- Joined
- Oct 10, 2012
- Messages
- 51,419
- Reaction score
- 207,062
Re: G4 Swine / July 1 WHO Briefing / transcript / Press briefings
Dr. Michael Ryan:
“With regard to the issue of the … You referred to the new virus. I think it’s important for us to clarify that the, I believe the virus you’re referring to is the Eurasian avian-like H1N1 swine influenza virus, which has been a virus that’s been under surveillance by Chinese authorities, and by the global influenza surveillance network around the world, the WHO collaborating centers.
It’s been under surveillance since 2011. And in fact, the publication, the most recent publication is a publication of all of that surveillance data over that time. And obviously reporting both on the evolution of that virus within the swine population, but also in terms of occupational exposures to workers over that time. It’s very important work, and it’s work that is again, carried out in collaboration with the WHO collaborating center at China CDC, the other collaborating centers around the world, including the WHO collaborating center for influenza. That’s CDC in Atlanta, and again shows the vital importance of the Global Influenza Surveillance and Response System.
The WHO collaborating center network, who keep these viruses under constant, constant surveillance. There are many, many, many avian flu and influenza viruses out there that have pandemic potential. We learned that in 2009, where a pandemic emerged in the Americas and we constantly need to stay on the alert. We need to continue to carry a very, very good surveillance on this G4 genotype, and we expect that, that will continue in the coming months and years. But again, it’s important I think, to reassure people that this is not a new virus, this is a virus that is under surveillance. We are concerned with any viruses that show potential to infect humans, and we will continue with our collaborating centers and the Global Influenza Surveillance and Response System, to keep this virus under close surveillance.”
[...]
“Costas Davinas: (33:55)
Yes. Thank you for taking my question. I’m coming back to the G4 virus. Can you give us, please, some [inaudible 00:34:04] information’s about this new virus and how dangerous can it be in connection with COVID-19? Thank you.
Dr. Michael Ryan: (34:14)
I will begin. I think I’ve given you, number one, this is a recent, a very recent publication. As I said, the viruses discussed in the paper that’s just been published are not new. And in fact, these G4 genotype was previously reported in swine in China, with the Harvard Veterinary Research Institute in a 2016 publication. The G4 genotype have been the dominant genotype in swine populations in China since 2016. The interesting finding in the latest report, is the zero prevalence among swine workers, which needs to be looked into carefully with an elevated zero prevalence rate against the G4 virus being reported. But this needs to be reviewed and looked at, and we need to really understand the study design, and the context, and exactly how that process was carried out.
Sporadic zoonotic infections, infections that transfer from swine to humans with the G4 genotype, have been reported in the past. And as I said, the WHO collaborating centers, particularly the one that China CDC and the one, our collaborating center in the United States at CDC in Atlanta, have been working on this Eurasian avian-like H1N1 variant. And this has been, as I said, under surveillance now for many years. What is interesting in collaboration with our flu and the WHO Global Influenza Surveillance and Response System in monitoring this, different candidate vaccine viruses of closely related strains have been developed by WHO at the China CDC, and they’re available for vaccine development and preparedness purposes. This has been a huge part of developing the …
… preparedness purposes. This has been a huge part of developing the pandemic influenza preparedness framework and ensuring that we are constantly checking on each and every one of these viruses and ensuring that candidate vaccine strands are available for rapid development should any one of these numerous strands ever show a likelihood of spreading successfully or efficiently in human populations. But again, I’d like just to restate that this is a finding from surveillance that’s been carried out over many years. These are not new viruses. We always take any variant strains of swine flu viruses extremely seriously, and that is why we will work and continue to work with our collaborating centers around the world on the surveillance and the development of countermeasures. Maria?
Dr. Maria Van Kerkhove: (36:48)
Just to add that this paper highlights the importance of the work that WHO and partners do with our collaborating centers globally, looking at viruses that are circulating in animals. This one happens to be a swine influenza virus, but there are other coronaviruses that are circulating in animals. There are other known pathogens that are out there.
And what we are doing is we are working with partner agencies at FAO and OIE, with academic institutions across the globe, with national centers for disease control all over the world to conduct surveillance in wild animals, to conduct surveillance in domesticated animals and to conduct surveillance in those animal workers to ensure that if there is a virus that spills over, that we are able to detect it, and we are able to detect it rapidly. There’s a whole body of work and scientists that are working globally on all continents that are looking at these viruses. And for those of you who are watching who may not know that, I think it’s important to mention.
So as Mike has said, this is not a new virus. This is a paper that is reporting on surveillance activities that have taken place between 2011 and 2018 in China. We’re grateful for all of our partners who are doing work in this area of looking at the epidemic potential. We always say essentially is a virus that is circulating in animals, it can spill over into humans. We call that a zoonotic transmission and the potential for that virus to continue to spread. But this is an important area of work and it highlights the need to remain focused on this. Even though COVID is happening globally, we still need to ensure that our surveillance programs for influenza are continuing and that we strengthen them so that we are able to detect these viruses spilling over rapidly.
Dr. Michael Ryan: (38:35)
If I could just add to that, that the global influenza surveillance and response system collaborate centers, national influenza centers around the world are constantly doing surveillance for seasonal influenza. And they are the basis of developing the yearly seasonal influenza vaccines for the northern and southern hemispheres. They carry out active and ongoing surveillance of avian flu strains around the world. All of that infrastructure has been turned and is now looking also at COVID-19 and doing sentinel surveillance for both COVID-19 and for other influenza viruses.
This is a hugely important global good. This is a massive piece of global health security. And I would remind our member states and our donors that this system is constantly underfunded and this system is in constant threat of being not funded. Our colleagues, Rick Brennan is online from the Eastern Mediterranean region. We spent the last five years investing and expanding the influenza surveillance and response capacities in the Eastern Mediterranean and on the African continent. And we now face a situation due to funding shortages that we may have to pull back on these investments. And these are the trade-offs and unfortunate trade-offs that we may have to make.“
Dr. Michael Ryan:
“With regard to the issue of the … You referred to the new virus. I think it’s important for us to clarify that the, I believe the virus you’re referring to is the Eurasian avian-like H1N1 swine influenza virus, which has been a virus that’s been under surveillance by Chinese authorities, and by the global influenza surveillance network around the world, the WHO collaborating centers.
It’s been under surveillance since 2011. And in fact, the publication, the most recent publication is a publication of all of that surveillance data over that time. And obviously reporting both on the evolution of that virus within the swine population, but also in terms of occupational exposures to workers over that time. It’s very important work, and it’s work that is again, carried out in collaboration with the WHO collaborating center at China CDC, the other collaborating centers around the world, including the WHO collaborating center for influenza. That’s CDC in Atlanta, and again shows the vital importance of the Global Influenza Surveillance and Response System.
The WHO collaborating center network, who keep these viruses under constant, constant surveillance. There are many, many, many avian flu and influenza viruses out there that have pandemic potential. We learned that in 2009, where a pandemic emerged in the Americas and we constantly need to stay on the alert. We need to continue to carry a very, very good surveillance on this G4 genotype, and we expect that, that will continue in the coming months and years. But again, it’s important I think, to reassure people that this is not a new virus, this is a virus that is under surveillance. We are concerned with any viruses that show potential to infect humans, and we will continue with our collaborating centers and the Global Influenza Surveillance and Response System, to keep this virus under close surveillance.”
[...]
“Costas Davinas: (33:55)
Yes. Thank you for taking my question. I’m coming back to the G4 virus. Can you give us, please, some [inaudible 00:34:04] information’s about this new virus and how dangerous can it be in connection with COVID-19? Thank you.
Dr. Michael Ryan: (34:14)
I will begin. I think I’ve given you, number one, this is a recent, a very recent publication. As I said, the viruses discussed in the paper that’s just been published are not new. And in fact, these G4 genotype was previously reported in swine in China, with the Harvard Veterinary Research Institute in a 2016 publication. The G4 genotype have been the dominant genotype in swine populations in China since 2016. The interesting finding in the latest report, is the zero prevalence among swine workers, which needs to be looked into carefully with an elevated zero prevalence rate against the G4 virus being reported. But this needs to be reviewed and looked at, and we need to really understand the study design, and the context, and exactly how that process was carried out.
Sporadic zoonotic infections, infections that transfer from swine to humans with the G4 genotype, have been reported in the past. And as I said, the WHO collaborating centers, particularly the one that China CDC and the one, our collaborating center in the United States at CDC in Atlanta, have been working on this Eurasian avian-like H1N1 variant. And this has been, as I said, under surveillance now for many years. What is interesting in collaboration with our flu and the WHO Global Influenza Surveillance and Response System in monitoring this, different candidate vaccine viruses of closely related strains have been developed by WHO at the China CDC, and they’re available for vaccine development and preparedness purposes. This has been a huge part of developing the …
… preparedness purposes. This has been a huge part of developing the pandemic influenza preparedness framework and ensuring that we are constantly checking on each and every one of these viruses and ensuring that candidate vaccine strands are available for rapid development should any one of these numerous strands ever show a likelihood of spreading successfully or efficiently in human populations. But again, I’d like just to restate that this is a finding from surveillance that’s been carried out over many years. These are not new viruses. We always take any variant strains of swine flu viruses extremely seriously, and that is why we will work and continue to work with our collaborating centers around the world on the surveillance and the development of countermeasures. Maria?
Dr. Maria Van Kerkhove: (36:48)
Just to add that this paper highlights the importance of the work that WHO and partners do with our collaborating centers globally, looking at viruses that are circulating in animals. This one happens to be a swine influenza virus, but there are other coronaviruses that are circulating in animals. There are other known pathogens that are out there.
And what we are doing is we are working with partner agencies at FAO and OIE, with academic institutions across the globe, with national centers for disease control all over the world to conduct surveillance in wild animals, to conduct surveillance in domesticated animals and to conduct surveillance in those animal workers to ensure that if there is a virus that spills over, that we are able to detect it, and we are able to detect it rapidly. There’s a whole body of work and scientists that are working globally on all continents that are looking at these viruses. And for those of you who are watching who may not know that, I think it’s important to mention.
So as Mike has said, this is not a new virus. This is a paper that is reporting on surveillance activities that have taken place between 2011 and 2018 in China. We’re grateful for all of our partners who are doing work in this area of looking at the epidemic potential. We always say essentially is a virus that is circulating in animals, it can spill over into humans. We call that a zoonotic transmission and the potential for that virus to continue to spread. But this is an important area of work and it highlights the need to remain focused on this. Even though COVID is happening globally, we still need to ensure that our surveillance programs for influenza are continuing and that we strengthen them so that we are able to detect these viruses spilling over rapidly.
Dr. Michael Ryan: (38:35)
If I could just add to that, that the global influenza surveillance and response system collaborate centers, national influenza centers around the world are constantly doing surveillance for seasonal influenza. And they are the basis of developing the yearly seasonal influenza vaccines for the northern and southern hemispheres. They carry out active and ongoing surveillance of avian flu strains around the world. All of that infrastructure has been turned and is now looking also at COVID-19 and doing sentinel surveillance for both COVID-19 and for other influenza viruses.
This is a hugely important global good. This is a massive piece of global health security. And I would remind our member states and our donors that this system is constantly underfunded and this system is in constant threat of being not funded. Our colleagues, Rick Brennan is online from the Eastern Mediterranean region. We spent the last five years investing and expanding the influenza surveillance and response capacities in the Eastern Mediterranean and on the African continent. And we now face a situation due to funding shortages that we may have to pull back on these investments. And these are the trade-offs and unfortunate trade-offs that we may have to make.“